What is Postmortem Genetic Testing?
Postmortem genetic testing is testing that is performed on a sample after an individual has died. The goal of postmortem genetic testing is often to try to identify the cause of death and/or identify if blood relatives are at-risk for a genetic disease or sudden death.
Genetic tests are a group of medical tests that search for alterations in chromosomes, genes, or biochemical metabolites. There are numerous different genetic tests and choosing the appropriate test depends upon an individual's medical and family history. Typically, genetic testing is ordered by a genetics specialist. The gold standard for molecular genetic testing is EDTA blood or fresh frozen tissue (heart, liver and spleen).
Once an individual has died, additional issues are introduced which can make the genetic testing process more difficult. Most commonly, these issues include sample collection/storage, insurance coverage and cost.
What Samples Do I Save for Genetic Testing?
There are a wide range of samples that are appropriate to save for genetic testing. Learn More
Young (< 40 years old) Sudden Death Is Often Genetic in Origin
- Up to 50% of sudden cardiac death (SCD) victims under age 35 years of age have no warning signs or family history of SCD. 1
- In approximately 30% of these cases there is no abnormality found in the heart on autopsy.
- Recent studies demonstrate that genetic testing helps to identify inherited cardiac disease in 25-35% of cases of SCD in the young. 1,2,3
- 15% of sudden infant death cases have been shown to have an underlying genetic cause. 4
- Postmortem genetic testing in sudden death cases is recommended by the Heart Rhythm Society and the European Heart Rhythm Association. 4
Why Should I Save a Sample?
The National Association of Medical Examiners (NAME) recommends retaining appropriate postmortem samples for genetic testing. Read More
In addition, genetic testing can:
- Identify or confirm the cause of the death.
- Confirm a suspected diagnosis.
- Provide the family with an explanation and closure.
- Allow other family members to be tested for a specific genetic disease that may be treatable.
Without a proper sample, genetic testing cannot be performed on deceased individuals.
When Should I Save a Sample for Potential Genetic Testing?
Diagnosis/Suspected Diagnosis/Cause of Death
- Sudden Infant Death Syndrome (SIDS) or Sudden Unexpected Infant Death (SUID)
- Cardiomyopathies (hypertrophic, idiopathic dilated, restrictive, arrhythmogenic, left ventricular noncompaction)
- Thoracic aneurysm
- Known genetic diagnosis
- Macroscopic findings at autopsy of fatty infiltration of the liver
- Sudden unexplained death, especially if during exercise or during sleep (see sudden cardiac death statistics below)
- Unexplained acidosis, hypoglycemia, and/or hyperammonemia
- Lethargy, vomiting, fasting in the 48 hours prior to death
Circumstances of Death
- Single motor vehicle accident
- Unexplained seizure
- Family history of sudden death or inherited heart disease
- Family history of SIDS/SUID or sudden death at any age
- Family history of Reye syndrome
- Family history of known genetic diagnosis
How Much Does Postmortem Genetic Testing Cost?
Genetic testing is dependent upon the specific tests ordered. Cost of testing is determined by the laboratory. Several laboratories offer self-pay options (payable by family or medical examiner/pathologist) of $250-$300.
Sample Letters of Medical Necessity
Cardiomyopathy PM Genetic Testing
Autopsy Negative PM Genetic Testing
What Information is Important to Share with the Surviving Family Members?
- Which sample(s) has been saved and how long it will be stored at the ME/coroner's office.
- Potential costs associated with postmortem genetic testing.
- This allows them to discuss the available options for the specimens with their managing physicians.
- The sudden unexplained death of a family member may warrant a medical evaluation for surviving family members.
- Example: If an inherited metabolic condition is suspected, then first-degree family members of the deceased individual could be advised to seek biochemical genetics evaluation.
- Genetic counselors are available to speak with the family.
- Genetic counselors can work with family members in a clinical setting to provide a risk assessment and help them navigate the available options for the saved DNA specimen.
- Information for families about postmortem genetic testing
Who Do I Contact if I Have Any Questions?
If you have questions regarding postmortem genetic testing, you can reach the NSGC Postmortem Group by emailing email@example.com. A genetic counselor with expertise in postmortem genetic testing will reply to your email inquiry within 48 hours.
Genetic counselors have a unique set of skills which make them experts in guiding both patients and providers through the genetic testing process. To help you navigate the postmortem genetic testing process you can find a cardiovascular or metabolic genetic counselor through using NSGC's Find A Genetic Counselor tool.
For the most up to date list of labs offering cardiovascular testing or any other testing please visit www.genetests.org or www.ncbi.nlm.nih.gov/gtr/ and search on a disease to find out which labs offer testing.
If you are interested in Genealogy testing (Genealogy is a DNA test looking for a persons’ ancestry/ethnicity), please contact the International Society of Genetic Genealogy: http://isogg.org/
- Tester DJ, et al. The molecular autopsy: Should the evaluation continue after the funeral? Pediatr Cardiol. 2012 Mar 33(3):461-70. Epub 2012 Feb 4.
- Behr 2003 et al “Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome.” Lancet. 2003 Nov 1, 362(9394):1457-9.
- Tan, et al. (2003). “Sudden unexplained death: Heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.” Circulation. 2005 Jul 12;112(2):207-13. Epub 2005 Jul 5.
- Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, and Zipes DP. Heart Rhythm. 2011 Aug, 8(8):1308-39. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies. This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
- Middleton O, Baxter S, Demo E, Honeywell C, Jentzen J, Miller F, Pinckard K, Reichard R, Rutberg J, Stacy C, and MacLeod H. NAME Position Paper: Retaining Postmortem Samples for Genetic Testing. Acad Forensic Pathol 2013 3 (2): 191-194.
- MacLeod H, Demo E, Honeywell C and Rutberg J. Genetic Counselors: An Important Resource for Families Following a Young Sudden Cardiac Death. Acad Forensic Pathol 2013 3 (2): 183-190.
- Loughrey CM, Preece MA, Green A. Sudden unexpected death in infancy (SUDI). Journal of Clinical Pathology 2005;58(1):20-21. doi:10.1136/jcp.2004.020677
- Mayo Medical labs Communique - The Metabolic Autopsy: Postmortem Screening in cases of Sudden, Unexpected Death
- Gulino SP, Burns, K, Gunther, W, MacLeod H. Acad Forensic Pathol. 2018 8(2): 347-391
- Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054. Epub 2018 Aug 16. Erratum in: J Am Coll Cardiol. 2018 Oct 2;72(14):1760. PMID: 29097296.Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, Chugh SS, Cornel MC, Gardner K, Ingles J, James CA, Jimmy Juang JM, Kääb S, Kaufman ES, Krahn AD, Lubitz SA, MacLeod H, Morillo CA, Nademanee K, Probst V, Saarel EV, Sacilotto L, Semsarian C, Sheppard MN, Shimizu W, Skinner JR, Tfelt-Hansen J, Wang DW. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm. 2021 Jan;18(1):e1-e50. doi: 10.1016/j.hrthm.2020.10.010. Epub 2020 Oct 19. PMID: 33091602; PMCID: PMC8194370.
- Wilde AAM, Semsarian C, Márquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; Document Reviewers; Aiba T, Bollmann A, Choi JI, Dalal A, Darrieux F, Giudicessi J, Guerchicoff M, Hong K, Krahn AD, MacIntyre C, Mackall JA, Mont L, Napolitano C, Ochoa JP, Peichl P, Pereira AC, Schwartz PJ, Skinner J, Stellbrink C, Tfelt-Hansen J, Deneke T. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases. Heart Rhythm. 2022 Jul;19(7):e1-e60. doi: 10.1016/j.hrthm.2022.03.1225. Epub 2022 Apr 4. PMID: 35390533.
Last Updated September 2023